课题基金 / 基金详情

Kinesin-mediated transport of Marek's disease virus

Kinesin-mediated transport of Marek's disease virus
驱动蛋白介导的马立克氏病病毒运输
批准号:
2391881
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Marek's disease is a fatal, highly contagious, neoplastic disease affecting chickens. It is caused by an alphaherpesvirus called Gallid herpesvirus-2 or Marek's Disease Virus (MDV). Pathogenesis of the virus can be characterised by exploring virus-host interactions which will enable future interventions that could impede MDV transmission. Therefore, the project aims to uncover the intracellular transport and trafficking of MDV. The virus travels to the nucleus and replicates where it will form viral capsids that will egress via the ER and Golgi for envelopment, then will return to the plasma membrane to infect other neighbouring cells. The virus itself is too large to passively diffuse through the cytoplasm (with a diameter of 200-300 nm), and instead exploits the host's cytoskeleton and motor proteins for cellular transport. It has been implicated that dynein and motors of the kinesin -3 family are instrumental in MDV transport. Therefore, the project will aim to identify how MDV interacts with motor proteins by establishing viral proteins that interact with these motor proteins using proximity-dependent biotinylation and mass spectrometry. As well as this, the binding of the viral candidate proteins with kinesin tails will be investigated to map interaction surfaces on kinesin and viral proteins. Motor protein truncations that lack viral binding sites will be explored and motor mutations in chickens that could potentially limit MDV spread and enhance meat production.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
Tom1L1在胞内体蛋白分选机制中功能的研究
  • 批准号:
    31171289
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2011
  • 负责人:
    刘宁生
  • 依托单位:
溶酶体依赖性TRAF2降解的机制
  • 批准号:
    30971501
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2009
  • 负责人:
    李联运
  • 依托单位: